We recently demonstrated that CDR1 overexpression in azole-resistant isolates of Candida albicans is due to its enhanced transcriptional activation and increased mRNA stability. In this study, we provide the first evidence of transcriptional regulation of CDR1 by Ncb2, the  subunit of NC2, a heterodimeric regulator of transcription. Conditional NCB2 null mutants displayed decreased susceptibility toward azole and an enhanced transcription of CDR1. Interestingly, Ncb2 associated with the CDR1 promoter under both repression and activation; however, an increase in recruitment was observed under both transient and constitutive activation states. By chromatin immunoprecipitation (ChIP) assay, we showed the preferential recruitment of Ncb2 to the core TATA region under activation (azole-resistant isolate), while under repression (azole-susceptible isolate) it was present at the TATA upstream region. Further, ChIP analysis revealed that Ncb2 binding was not restricted to the CDR1 gene; instead, it was observed on the promoters of genes coregulated with CDR1 by the transcription activator Tac1. The tac1⌬ null mutants, which fail to show the drug-induced transient activation of CDR1, also showed no increase in Ncb2 recruitment at the promoter. Taken together, our results show that Ncb2, in conjunction with Tac1, is involved in the transcriptional activation of CDR1, opening up new therapeutic possibilities to combat multidrug resistance (MDR) in C. albicans.Candida albicans is an opportunistic human pathogen which mostly infects immunocompromised patients. It has gained considerable importance due to its ability to acquire resistance to a wide range of drugs during the treatment of its infection. Among various mechanisms contributing to acquired resistance against antifungal agents, drug efflux represents an important strategy adopted by the pathogen (33,37,39,40,43,45). Thus, most of the clinical, multidrug-resistant (MDR) isolates of C. albicans are shown to overexpress CDR1, CDR2, or MDR1 drug efflux pump-encoding genes. Cdr1 and Cdr2 belong to the ATP-binding cassette (ABC) superfamily of transporters and use energy driven from ATP hydrolysis to functionally transport drugs outside the cells. Mdr1, on the other hand, is a proton/drug antiporter which belongs to the superfamily of major facilitators (MFS). Notably, major multidrug transporters of Candida spp. belonging to different superfamilies, such as ABC or MFS, display promiscuity toward substrate specificity and use different mechanisms of drug extrusion (32). The regulatory circuits which control the gene expression of either ABC or MFS efflux proteins also are different (25,29,38).The CDR1 gene encodes a major drug efflux protein which is regulated both transcriptionally and posttranscriptionally. The regulation of CDR1 has been extensively studied by us and other groups (4,5,6,8,18,21,35). It has been shown that the CDR1 promoter harbors various consensus cis elements (Sp1, AP-1, and Y-box) as well as specific cis-elements, such as as BRE, NRE (for Negative ...